CAR T cell therapy for T cell lymphoma shows promise in phase I trial
A first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
Read MoreA first-in-human phase I clinical trial of patients with relapsed or refractory T cell lymphoma found early signals of anti-tumor efficacy and safety.
Read MoreThis new technology can effectively regulate gene expression, a promising solution to improve gene therapy clinical applications.
Read MoreThis study is the first to show that rotavirus-altered lipid metabolism in the intestine plays a role in the disease.
Read MoreThis study in animal models suggests that a natural sugar could counter age-associated urothelial dysfunction in addition to limiting recurring UTIs.
Read MoreHuman intestinal enteroids have revolutionized the study of gastrointestinal viruses like rotavirus.
Read MoreIn the not-so-distant future, people might be able to tune in to their favorite news source for an update on their community health status.
Read MoreThis new biomarker offers insights into how meningioma patients with different gene expression patterns respond differently to treatments
Read MoreNearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read MoreAn improved tissue clearing protocol called EZ Clear renders entire organs, like this mouse heart, optically transparent for imaging.
Read MoreNeurons producing neurotransmitters GABA and dopamine can differentially modulate different target neurons involved in the sense of smell.
Read More